Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer
Jennifer A. Morrison(University of Colorado Anschutz Medical Campus), Bryan R. Haugen(University of Colorado Cancer Center)
Cited by 102
Related Papers
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone Withdrawal
|The Journal of Clinical Endocrinology & Metabolism|2006|198
Thyroid hormone resistance and increased metabolic rate in the RXR-γ–deficient mouse
|Journal of Clinical Investigation|2000|105
Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer
|The Journal of Clinical Endocrinology & Metabolism|2009|65
Single-Dose Rexinoid Rapidly and Specifically Suppresses Serum Thyrotropin in Normal Subjects
|The Journal of Clinical Endocrinology & Metabolism|2006|53